key: cord-0938643-x9m3idln authors: Cottler, Linda B.; Goldberger, Bruce A.; Nixon, Sara Jo; Striley, Catherine W.; Barenholtz, Elan; Fitzgerald, Nicole D.; Taylor, Sean M.; Palamar, Joseph J. title: Introducing NIDA’s New National Drug Early Warning System date: 2020-09-14 journal: Drug Alcohol Depend DOI: 10.1016/j.drugalcdep.2020.108286 sha: ae1e455913919f6def4d0b3d83dc843bb6f2c40c doc_id: 938643 cord_uid: x9m3idln nan Deaths from fentanyl and from psychostimulants are increasing (Kariisa et al., 2019; O'Donnell et al., 2020) and new psychoactive substances (NPS) continue to emerge (US Drug Enforcement Administration [DEA], 2020). Methods of drug administration are also rapidly changing, with record-high increases in vaping of cannabis among adolescents (Miech et al., 2019) . Further, the coronavirus disease 2019 (COVID-19) appears to be associated with drug overdoses and changes in use behavior (Volkow, 2020) . While lagged indicators, such as national estimates of drug use, are useful for monitoring patterns of drug use and associated consequences, a national system to detect dangerous trends as they emerge is needed. and on-the-ground epidemiologic investigations within the 18 sites that include hair testing for exposure fentanyl and to over 100 NPS. Other direct sources of data will include outbreak investigations, a virtual community-based HealthStreet cohort of people self-reporting drug use, and web monitoring via machine-learning algorithms deployed to darknet drug markets and forums. Another focus will be on other known high-risk populations such as nightclub and dance festival attendees and "psychonauts" (Peacock et al., 2019) . Through a new NIDA Supplement, we have begun to examine the effect of COVID-19 on reporting and detection of overdose and other drug related outcomes through a longitudinal study of key informants involving medical examiners/coroners, funeral directors, emergency medical technicians, and syringe exchange workers, in Early Warning Network cities. Two additional goals are fundamental: dissemination and training. Dissemination is modeled after the Florida drug-Related Outcomes Surveillance and Tracking System (FROST). Results will also be disseminated to the community through our website (http://ndews.org/) and through webinars with an aim to reach people who use drugs and providers who care for people who use drugs. Our NIDA T32 Training Program and our NDEWS Research Lab is also training the next generation of scientists in surveillance science; students, fellows and junior scientists are conducting research, analyzing the data, writing, publishing and sharing results with the public and scientists in epidemiology, public health, forensic toxicology, psychology, artificial intelligence, and machine learning. J o u r n a l P r e -p r o o f Drug overdose deaths involving cocaine and psychostimulants with abuse potential -United States Trends in reported marijuana vaping among US adolescents Notes from the field: opioid-involved overdose deaths with fentanyl or fentanyl analogs detected New psychoactive substances: challenges for drug surveillance, control, and public health responses US Drug Enforcement Administration, 2020. National Forensic Laboratory Information System: NFLIS-Drug 2019 Midyear Report Collision of the COVID-19 and addiction epidemics GIS: geographic information system, NFLIS: National Forensic Laboratory Information System This system relies on trends found by the scientific network funded by the NIH and other agencies, as well as the community at large. This research is supported by grants through the National Institute on Drug Abuse: U01DA051126 (Cottler) and T32DA035167. The National Institutes of Health provided financial support for the project and the preparation of the manuscript but did not have a role in the writing of the manuscript, nor the decision to submit the present research. All authors are responsible for this report and all authors approved the final manuscript as submitted. This research is supported by grants through the National Institute on Drug Abuse: U01DA051126 (Cottler) and T32DA035167. The National Institutes of Health provided financial support for the project and the preparation of the manuscript but did not have a role in the writing of the manuscript, nor the decision to submit the present research. No conflicts declared.